4//SEC Filing
Robinson Ryan F. 4
Accession 0001209191-23-053405
CIK 0001827506other
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 8:30 PM ET
Size
9.4 KB
Accession
0001209191-23-053405
Insider Transaction Report
Form 4
Robinson Ryan F.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-10-19+40,211→ 40,211 totalExercise: $13.92Exp: 2033-08-14→ Common Stock (40,211 underlying) - Award
Employee Stock Option (Right to Buy)
2023-10-23+16,000→ 16,000 totalExercise: $9.46Exp: 2033-10-23→ Common Stock (16,000 underlying)
Footnotes (4)
- [F1]Under the terms of an Agreement and Plan of Merger dated as of June 22, 2023 by and among Tourmaline Bio, Inc. ("Tourmaline"), the Issuer and Terrain Merger Sub, Inc., a wholly owned subsidiary of the Issuer ("Merger Sub"), on October 19, 2023, Merger Sub merged with and into Tourmaline (the "Merger"), with Tourmaline surviving the Merger as a wholly owned subsidiary of the Issuer. Upon the closing of the Merger, each share of Tourmaline common stock was converted into the right to receive 0.07977 of a share of the Issuer's common stock, after giving effect to a reverse stock split of the Issuer's common stock of 10-for-1 and each outstanding option to purchase shares of Tourmaline common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock, on the same terms and conditions as were applicable to such Tourmaline stock option prior to the Merger, as adjusted for the exchange ratio and the reverse stock split.
- [F2]The shares subject to the option vest as to 25% of the shares on July 5, 2024 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.
- [F3]Received in exchange for a stock option to acquire 504,100 shares of Tourmaline common stock pursuant to the Merger Agreement.
- [F4]The shares subject to the option vest as to 25% of the shares on October 23, 2024 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Tourmaline Bio, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001997834
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 8:30 PM ET
- Size
- 9.4 KB